Q4 2023 Holdings
Filed 2024-02-14 | 84 holdings | $8.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen, Inc.(SRZNW) | W EXP 8/11/2026 | 86889P117 | $16.2K | 833,333 | 0.0% |
| Tyra Biosciences, Inc.(TYRA) | COM | 90240B106 | $146.9K | 10,607 | 0.0% |
| Atreca, Inc.(BCELUSD) | CL A COM | 04965G109 | $287.4K | 2,177,499 | 0.0% |
| Foghorn Therapeutics Inc.(FHTX) | COM | 344174107 | $290.4K | 45,027 | 0.0% |
| Cabaletta Bio, Inc.(CABA) | COM | 12674W109 | $302.6K | 13,331 | 0.0% |
| Protara Therapeutics, Inc.(TARA) | COM STK | 74365U107 | $374.4K | 199,671 | 0.0% |
| Aadi Bioscience, Inc.(WHWK) | COM | 00032Q104 | $508.5K | 251,727 | 0.0% |
| PMV Pharmaceuticals, Inc.(PMVP) | COM | 69353Y103 | $998.3K | 322,024 | 0.0% |
| Pfizer Inc.(PFE) | COM | 717081103 | $1.0M | 35,000 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $1.1M | 1,764,546 | 0.0% |
| Aligos Therapeutics, Inc. | COM | 01626L105 | $1.4M | 2,076,400 | 0.0% |
| Kala BIO, Inc.(KALA) | COM | 483119202 | $1.9M | 266,613 | 0.0% |
| Achilles Therapeutics plc(698) | SPONSORED ADS | 00449L102 | $1.9M | 2,102,792 | 0.0% |
| Compass Therapeutics, Inc.(CMPX) | COM | 20454B104 | $2.4M | 1,557,630 | 0.0% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $2.5M | 1,086,115 | 0.0% |
| Century Therapeutics, Inc.(IPSC) | COM | 15673T100 | $2.6M | 797,460 | 0.0% |
| Praxis Precision Medicines, Inc. | COM | 74006W108 | $2.9M | 131,533 | 0.0% |
| Vaxcyte, Inc.(PCVX) | COM | 92243G108 | $3.1M | 48,885 | 0.0% |
| Perspective Therapeutics, Inc. | COM | 46489V104 | $3.1M | 7,639,703 | 0.0% |
| Talis Biomedical Corporation(TLIS) | COM | 87424L207 | $3.8M | 508,323 | 0.0% |
| Design Therapeutics, Inc.(DSGN) | COM | 25056L103 | $4.0M | 1,500,000 | 0.0% |
| Leap Therapeutics, Inc.(CYPH) | COM | 52187K200 | $4.9M | 1,172,175 | 0.1% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $5.2M | 245,431 | 0.1% |
| Mirum Pharmaceuticals, Inc.(MIRM) | COM | 604749101 | $5.6M | 190,476 | 0.1% |
| Invitae Corporation | Series A Notes 4.5% 3/15/2028 | 46185LAH6 | $6.3M | $9,274,000 | 0.1% |
| Hookipa Pharma Inc. | COM | 43906K100 | $6.6M | 8,128,151 | 0.1% |
| Taysha Gene Therapies, Inc.(TSHA) | COM SHS | 877619106 | $7.1M | 4,004,756 | 0.1% |
| Tango Therapeutics, Inc.(TNGX) | COM | 87583X109 | $7.4M | 750,000 | 0.1% |
| Opthea Limited | SPONSORED ADS | 68386J208 | $7.6M | 2,588,645 | 0.1% |
| Athira Pharma, Inc. | COM | 04746L104 | $7.7M | 3,153,807 | 0.1% |
| Celcuity Inc.(CELC) | COM | 15102K100 | $7.8M | 535,478 | 0.1% |
| Sagimet Biosciences Inc.(SGMT) | COM SER A | 786700104 | $7.9M | 1,456,518 | 0.1% |
| Sana Biotechnology, Inc.(SANA) | COM | 799566104 | $8.2M | 2,000,000 | 0.1% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $8.7M | 10,969,282 | 0.1% |
| Neurogene Inc.(NGNE) | COM | 64135M105 | $8.8M | 453,516 | 0.1% |
| Prime Medicine, Inc.(PRME) | COM | 74168J101 | $9.1M | 1,028,466 | 0.1% |
| Celldex Therapeutics, Inc.(CLDX) | COM | 15117B202 | $9.8M | 247,644 | 0.1% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $10.6M | 343,000 | 0.1% |
| 2seventy bio, Inc.(TSVT*) | COM | 901384107 | $10.7M | 2,497,526 | 0.1% |
| Stoke Therapeutics, Inc.(STOK) | COM | 86150R107 | $10.7M | 2,030,134 | 0.1% |
| ARS Pharmaceuticals, Inc.(SPRY) | COM | 82835W108 | $11.0M | 2,006,451 | 0.1% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $12.8M | 1,160,117 | 0.1% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $13.9M | 14,614,264 | 0.2% |
| Day One Biopharmaceuticals, Inc.(DAWN) | COM | 23954D109 | $14.6M | 1,000,000 | 0.2% |
| TScan Therapeutics, Inc.(TCRX) | COM | 89854M101 | $16.2M | 2,784,792 | 0.2% |
| Immunovant, Inc.(IMVT) | COM | 45258J102 | $17.9M | 425,009 | 0.2% |
| Gracell Biotechnologies Inc. | SPONSORED ADS | 38406L103 | $20.9M | 2,080,000 | 0.2% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $21.1M | 169,934 | 0.2% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $23.6M | 1,691,530 | 0.3% |
| Monte Rosa Therapeutics, Inc.(GLUE) | COM | 61225M102 | $27.8M | 4,916,095 | 0.3% |